AmysFoundation

Amy’s Foundation was established with the primary goal of fulfilling Amy’s wish to develop a highly effective early detection test for ovarian cancer as well as cancers related to the BRCA 1 and BRCA 2 gene mutations. The foundation aims to identify these cancers at a stage when they are still localized and treatable, thereby increasing the likelihood of curing them before they have the chance to spread or advance to a more severe stage. By focusing on early detection, Amy’s Foundation strives to make a significant impact on survival rates and overall outcomes for individuals affected by these specific types of cancers.